effectively turning into an expanded “second liver.” The kidneys, which concentrate protein-bound toxins like PFAS, show strong associations with renal cell carcinoma. The lungs, exposed to airborne and blood-borne toxins, often sequester particles and chemicals in pulmonary tumors. These are all good examples of heavily burdened tissues.
The liver, kidneys, and lungs — the body’s primary detoxification and exposure organs — frequently develop tumors when their toxic load becomes overwhelming. The tumor acts as a secondary storage vault for the excess burden.
Other organs possess unique biological features that make them effective “vaults”
● The prostate has high levels of fatty acid transporters (such as CD36) and a natural capacity to store lipids in droplets, making it well-suited to sequester damaged oils.
● The breast is highly estrogen-sensitive and has a strong capacity for local estrogen metabolism and uptake. This allows it to act as an effective sequestration site for excess estrogen and its oxidative byproducts.
● The colon has a large surface area and direct exposure to gut contents, enabling it to wall off mycotoxins and dietary aldehydes.
These are great examples of organs best equipped to safely sequester and isolate the toxic load.
Tumors form in tissues best equipped to sequester toxins.
The body strategically selects organs that have special biological features — such as high transporters, storage capacity, or direct exposure — making them effective vaults for isolating specific toxins.
One of the most telling observations in cancer epidemiology is what doesn’t happen.
Primary tumors in the heart (cardiac cancer) are extraordinarily rare — so rare that many cardiologists go their entire careers without seeing a single case. The same is true for the spleen. These two organs almost never develop primary cancers, even though they are exposed to the same circulating toxins as every other tissue. From the perspective of TSTST, this is not surprising. It is strategic.
The heart and spleen are critically important for immediate survival. Any significant tumor growth in the heart would quickly impair cardiac function and threaten life within days or weeks.
Similarly, any significant tumor growth in the spleen would rapidly impair its ability to clear damaged blood cells and fight infections, posing an immediate threat to survival. The body appears to avoid using these vital organs as sequestration sites precisely because forming a tumor there would be too costly.
The mainstream model cannot explain why primary tumors almost never form in the heart or spleen.
TST offers a clear functional reason: the body strategically avoids using these critical organs as sequestration sites because even small tumors there would rapidly threaten survival. Instead, it prefers lower-stakes tissues such as the prostate, breast, colon, and liver.
Instead, the body preferentially chooses “lower-stakes” tissues — such as the prostate, breast, colon, or liver — that can better tolerate the formation of a storage vault without immediately compromising survival.
These organs can expand, store lipids or metals, and undergo metabolic adaptation with less immediate risk to the organism.
The toxin-to-organ mapping
We are now in an exciting position to create a toxin-to-organ mapping. The idea is that specific toxins map onto specific organs. This can happen for two key reasons:
The toxin directly impacts that organ (adding to that organ’s toxic burden).
The toxin can be easily sequestered and stored in that organ.
The second reason is especially interesting, as some toxins go to certain organs just because that organ is well equipped to handle that toxin.
For this toxin-to-organ mapping, some of the strongest links that appear in the medical literature are summarized in the figure on the next page, which draws arrows linking specific toxins to specific organs (darker arrows indicate stronger links).
Toxin-to-Organ Mapping in TST. Different toxins preferentially burden specific organs based on the tissue’s biology and storage capacity. Tumors then form as localized storage and detoxification vaults in those high-burden tissues.
These mappings are not coincidences.